Infinity Pharmaceuticals retains regular Real Value of $1.9554999999999998 per share. The prevalent price of the corporation is $2.24. Based on Macroaxis valuation methodology, the corporation appears to be over valued. Macroaxis calculates value of Infinity Pharmaceuticals from evaluating the corporation fundamentals such as Shares Outstanding of 51.96M, Return On Asset of
(24.62)% and Return On Equity of (64.26)% as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we encourage to acquire undervalued assets and to sell overvalued assets since at some point stocks prices and their ongoing real values will come together.
Valuation Drivers Correlation
|Time Horizon||30 Days Login to change|